eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiology

Aortic Valve Insufficiency

Author: Mohsen Saidinejad, MD, Assistant Professor of Pediatrics and Emergency Medicine, George Washington University School of Medicine and Health Sciences; Attending Physician, Department of Pediatric Emergency Medicine, Children's National Medical Center
Coauthor(s): Russell R Cross, MD, Assistant Professor of Pediatrics, George Washington University Medical Center; Attending Cardiologist, Director of Cardiac MRI, Division of Cardiology, Medical Unit Director of Heart and Kidney Unit, Children's National Medical Center-Main Hospital
Contributor Information and Disclosures

Updated: Oct 26, 2009

Introduction

Background

Aortic valve insufficiency results from leakage and backflow of blood that is ejected from the left ventricle (LV) into the ascending aorta back into the left ventricle.

Many mechanisms contribute to aortic valve insufficiency. These include abnormalities of the aortic valve leaflets and pathologies of the proximal aortic root. This article primarily focuses on aortic valve insufficiency caused by abnormalities in the aortic valve leaflets.

Anatomy of the aortic valve

The aortic valve is composed of 3 thin leaflets (ie, cusps) that project from the wall of the proximal ascending aorta. These leaflets and their respective sinuses of Valsalva are termed left, right, and noncoronary.

Embryologic development of the aorta

In the embryonic stage, the truncus arteriosus connects to the dorsal aspect of the aorta via 6 pairs of aortic arches. The separation of truncus arteriosus into 2 great arteries results from the fusion of the aorticopulmonary septum and the truncus septum. The semilunar valves and their related sinuses are created by absorption and the hollowing out of tissue at the distal side of the truncus ridges.

Many mouse single-gene-knockout models of truncus arteriosus have been reported (eg, Sox4 null, Tbx1 null, pax3Splotch), although only NFATc1 null and Sox4 null display absent semilunar cusps. Ablation of a particular region in the cranial neural crest also results in truncus arteriosus, at least in the chick.

Aortic valve insufficiency can be due to, or associated with, congenital heart disease.

  • Ventricular septal defect of the membranous (conoventricular) or conal septal (infundibuloventricular) types
  • Bicuspid (ie, bicommissural) aortic valve
  • Subvalvular aortic stenosis
  • Dysplasia of valve cusps, without fusion of commissures
  • Absence of 2 or 3 aortic valve leaflets

Acquired valvular aortic insufficiency

Causes of acquired aortic valve insufficiency include endocarditis, trauma, systemic diseases, and connective tissue syndromes. Systemic diseases that cause aortic valve insufficiency include the following:

Syndromes that lead to aortic valve insufficiency include the following:

Recently, the percentage of individuals with aortic valve insufficiency caused by aortic root disease has been steadily increasing compared with the percentage of those with valvular disease. In fact, more than half of patients who present with pure aortic regurgitation (AR) without any associated cardiac anomalies have aortic valve insufficiency caused by aortic root disease.

Aortic regurgitation. Color Doppler echocardiogra...

Aortic regurgitation. Color Doppler echocardiogram.

Aortic regurgitation. Color Doppler echocardiogra...

Aortic regurgitation. Color Doppler echocardiogram.


Pathophysiology

Regardless of etiology, aortic valve insufficiency results in volume overload on the LV because the LV is forced to pump the entire diastolic volume received from the left atrium and the regurgitant volume from the aorta through an incompetent aortic valve. Over time, such volume overload (ie, increased preload) causes eccentric hypertrophy of the LV. (Compare this with the concentric hypertrophy observed in aortic stenosis.)

Chronic aortic insufficiency

In long-standing aortic regurgitation, this compensatory mechanism begins to deteriorate. When LV function cannot continue to compensate for volume overload, the LV dilates, and LV end-diastolic volume increases, even without further increase in aortic regurgitation volume. The LV thickness–to–chamber size ratio decreases. This causes an increase in systolic wall tension and a decrease in ejection fraction, stroke volume, and ventricular emptying. This larger end-systolic volume leads to progressively larger end-diastolic volume.

With progressive increases in wall tension, a mismatch occurs between oxygen demand and supply. Supply, which is always abnormally tenuous because of the lower-than-normal coronary driving pressure (difference in aortic diastolic pressure and ventricular diastolic pressure), cannot keep up with the increased demand. Interstitial fibrosis begins to occur, reducing wall compliance and further increasing end-diastolic LV pressure. If untreated, this interstitial fibrosis leads to elevated left atrial pressure and pulmonary venous congestion, especially during exercise. Ventricular ectopy is another manifestation of the oxygen supply-demand mismatch.

Acute severe aortic insufficiency

In acute severe aortic valve insufficiency due to endocarditis or sudden trauma, the LV cannot immediately respond with increased stroke volume to facilitate proper emptying because the element of eccentric hypertrophy is missing. As a result, LV diastolic pressure suddenly rises. Volume overload in the LV results in an early closure of the mitral valve during diastole. This occurs as a natural defense mechanism to protect the pulmonary venous system from the high-pressure regurgitant backflow coming from the high-pressure LV chamber.

Systolic pressures remain effectively unchanged in the aorta and the LV. Because of the increase in LV diastolic pressure, the pulse pressure may not significantly widen in acute severe aortic valve insufficiency. Tachycardia and early closure of the mitral valve are the compensatory mechanisms here.

Natural history

The natural history of aortic valve insufficiency after diagnosis is as follows:

  • Asymptomatic patients with normal LV systolic function
    • The 5-year survival rate is approximately 75%.
    • The 10-year survival rate is approximately 50%.
    • Progression to symptoms, LV dysfunction, or both occurs in fewer than 6% of patients per year.
    • Progression to asymptomatic LV dysfunction occurs in fewer than 3.5% of patients per year.
    • Sudden death occurs in fewer than 0.2% of patients per year.
  • Asymptomatic patients with LV systolic dysfunction: Progression to cardiac symptoms occurs in more than 25% of patients per year.
  • Symptomatic patients: The mortality rate is higher than 10% per year.

Most findings in patients with aortic valve insufficiency are related to LV volume overload and eventual myocardial dysfunction.

Individuals with chronic aortic valve insufficiency may be asymptomatic for several years. This is because of adaptation of the LV to the pressure dynamics generated from long-standing volume overload. Many patients with chronic aortic valve insufficiency are no longer in the pediatric age group by the time signs and symptoms appear.

However, in acute severe aortic valve insufficiency, the LV does not have the ability to adapt to sudden volume overload resulting from aortic valve insufficiency. In this setting, LV failure and cardiac collapse occur. They are manifested as chest discomfort, dyspnea, and hypotension.

Frequency

United States

An estimated 5 million Americans have at least one form of heart valve disease. In 2000, 1 million Americans were affected by congenital heart disease. This is a 3-fold increase from 300,000 in 1980. This figure is projected to increase to 1.4 million in the year 2020. Risk of premature death, complications, and the need for medication because of congenital heart disease is at least 50%.

In approximately two thirds of patients with aortic regurgitation, the disease is rheumatic in origin, resulting in thickening, deformation, and shortening of the individual aortic valve cusps. This leads to changes that prevent their proper opening during systole and closure during diastole. A rheumatic origin is less common in patients with isolated aortic regurgitation.

International

Data are similar to those of the United States. Acute rheumatic fever is associated with varying degrees of valvulitis and myocarditis. A New Zealand study focused on LV mechanics during and after acute rheumatic fever.1 The study found that the contractile dysfunction during and after acute rheumatic fever evolves in a manner dependent on the degree and type of aortic valve insufficiency and may be influenced by surgical intervention. The study concluded that mechanical factors are the most important contributors to myocardial damage during and after an episode of acute rheumatic fever in children.

Mortality/Morbidity

Mortality and morbidity associated with aortic valve insufficiency are related to the following parameters:

  • Duration of aortic valve insufficiency
  • Severity of valve incompetence
  • Compensatory mechanisms
  • Postsurgical complications for valve replacement in symptomatic severe aortic valve insufficiency

In patients with chronic aortic valve insufficiency, in whom LV diastolic function remains stable and compensatory mechanisms have evolved over time, the presence of a new acute lesion may adversely affect the LV dysfunction. This can have a significant impact on valve function and blood flow dynamics and may ultimately facilitate decompensation. Therefore, even a person with compensated chronic severe aortic valve insufficiency should be considered at a high risk of decompensation with respect to life-threatening cardiac complications. Furthermore, because of the lower-than-normal coronary driving pressure, patients with severe aortic valve insufficiency are difficult to successfully resuscitate following cardiovascular collapse.

Most natural history data are from the adult population with a history of several years of aortic valve insufficiency. According to these data, in patients who have angina, the 5-year survival rate of uncorrected severe aortic valve insufficiency is 50%. Once syncope develops, almost 50% of patients who do not undergo correction die within 3 years. Once heart failure develops, 50% of uncorrected patients die within 2 years. Compare this with an approximate 1-5% mortality rate in patients with surgical correction.

Race

No racial predilection is reported.

Sex

Approximately three fourths of patients with pure or predominant aortic valve insufficiency are males. In patients who have associated mitral valve disease, the incidence is higher in females than in males.

Age

Other than aortic valve insufficiency associated with congenital heart disease, the incidence of aortic valve insufficiency is not age related.

Clinical

History

Presenting symptoms in aortic valve insufficiency include the following:

  • Chronic severe aortic valve insufficiency
    • Gradual enlargement of the left ventricle (LV) and gradual increase of stroke volume in most cases 
    • No symptoms for many years in most patients with chronic aortic valve insufficiency
    • No symptoms for decades in most patients with chronic moderate aortic valve insufficiency
    • Exertional dyspnea (common)
    • Orthopnea (common)
    • Paroxysmal nocturnal dyspnea (common)
    • Angina pectoris (less common)
    • Abdominal discomfort (less common)
    • Syncope (rare)
    • Nocturnal angina with diaphoresis (rare)
  • Causes of symptoms in chronic severe aortic valve insufficiency
    • The onset of myocardial ischemia and diastolic dysfunction
    • Splanchnic ischemia, which may cause abdominal discomfort
  • Symptoms associated with acute severe aortic valve insufficiency
    • Chest discomfort
    • Dyspnea
    • Hypotension
    • Uncomfortable awareness of heartbeat/palpitations
    • Chest pain
    • Sudden cardiovascular collapse
  • Cause of symptoms in acute severe aortic valve insufficiency
    • Sudden drop in coronary driving pressure
    • Increased filling pressure of the LV
    • Increased left atrial pressure
    • Low cardiac output

Physical

Physical examination findings can be associated with the signs and symptoms of various degrees of severity of insufficiency and with the status of LV compensation. These may include physical findings of widening of pulse pressure or volume overload. In chronic aortic valve insufficiency, systolic pressures are abnormally elevated and diastolic pressures are abnormally low, which may indicate the extent of aortic valve insufficiency.

Coexisting cardiac pathology, such as a ventricular septal defect or aortic stenosis, may also be revealed during physical examination.

  • Physical findings in chronic severe aortic valve insufficiency
    • Water-hammer pulse - Bounding radial pulse with elevation of the patient's arm
    • Corrigan pulse - A quick filling and collapse of carotid pulse
    • de Musset sign - Head bobbing with each systole
    • Bisferiens pulse - Characterized by 2 systolic peaks of equal or unequal magnitudes separated by a midsystolic trough; usually detected well in the carotid artery, but noted better in the brachial and femoral pulses in severe chronic aortic valve insufficiency
    • Traube sign - Bounding pistol shot–like femoral artery pulse during systole and diastole
    • Müller sign - Pulsations of the uvula during systole
    • Duroziez sign - Murmur heard over femoral artery when compressed; heard during systole when the femoral artery is compressed proximally and heard during diastole when the femoral artery is compressed distally
    • Quincke sign - Pulsations of the nail beds with systole, when the nail is distally compressed 
    • Hill sign - A greater than 40 mm Hg elevation of the popliteal systolic pressure over that of the brachial systolic pressure
  • Physical findings in chronic aortic valve insufficiency associated with increased stroke volume
    • Displacement of the point of maximal impulse inferiorly and laterally, consistent with the volume overload and increased LV chamber size
    • Hyperdynamic apical impulse
    • Diastolic thrill, consistent with rapid forceful ventricular emptying
    • Systolic thrill over suprasternal notch or carotid arteries, consistent with increased stroke volume
  • Auscultatory findings in chronic severe aortic valve insufficiency
    • Soft S1
    • S2 abnormalities, which may include absent S2, single S2, or paradoxical splitting of S2
      • Soft or absent A2 portion of S2 can be caused by incomplete or abnormal closure of the aortic valve.
      • Absent P2 portion of S2 may be caused by the murmur of AI during the early diastole.
      • Paradoxical splitting of S2 can be caused by delayed closure of the aortic valve because of increased preload volume.
    • Systolic murmur - Caused by forceful ejection of overloaded volume from the LV, which results in aortic distension
    • S3 - Can be heard when filling of the LV continues through an already expanded and stretched LV; may suggest an extremely high-end systolic volume of the LV and may be an early sign of impeding LV failure and severe AR
    • Diastolic murmur
  • Quality of the murmur of chronic aortic valve insufficiency
    • High frequency
    • Begins immediately after A2
    • Best heard with patient sitting up or leaning forward (increases the setting of preload and volume return to the heart, accentuates the murmur of aortic valve insufficiency)
    • Best heard with deep expiration
    • Holodiastolic decrescendo (signifies severe insufficiency)
  • Auscultatory differentiation between chronic severe and chronic mild aortic valve insufficiency
    • Intensity and duration of the murmur correlate with the amount of volume overload and stroke volume ejected from the LV to the aorta.
    • A murmur that is confined to the early part of diastole correlates with mild AR. This murmur is also high pitched.
    • A murmur that extends through diastole correlates with severe aortic valve insufficiency.
    • A musical-type murmur may be related to a perforated aortic valve cusp.
  • Determining where the aortic valve insufficiency murmur is best heard
    • A murmur that is best heard at the left sternal border at the third and fourth intercostal spaces suggests a primary valvular disease.
    • A murmur that is best heard along the right sternal border suggests proximal aortic root dilatation.
    • An Austin Flint murmur is a mid-diastolic to late-diastolic rumble, which is best heard at the apex.
  • The Austin Flint murmur
    • This mid-diastolic to late-diastolic murmur is present when a surge of flow from the left atrium to the LV is counteracted by the regurgitant flow from the aorta to the LV as it courses back into the mitral valve. The regurgitant flow causes constriction of the mitral opening and accentuates the rumble of the forward flow from the left atrium through the mitral valve.
    • The Austin Flint murmur is similar to the murmur of mitral stenosis. The difference is that S1 is not as loud in aortic valve insufficiency as it is in mitral stenosis.
    • Onset, duration, and termination of the Austin Flint murmur are related to the amount of LV volume overload and the end-diastolic pressure in the LV chamber. In the most severe form of increased end-diastolic pressure, the murmur is heard in early to mid diastole.
    • The Austin Flint murmur may be graded 1-4, depending on the ejection fraction and stroke volume. The murmur can be transmitted upward to the carotid vessels.
  • Certain maneuvers that can alter the intensity of the murmur in chronic aortic valve insufficiency
    • Sitting up or leaning forward causes increased volume overload and increased LV end-diastolic pressure; therefore, it increases the intensity of the murmur.
    • Straining, Valsalva maneuver, and hypotension decrease the intensity of the murmur.
  • Physical findings in acute severe aortic valve insufficiency
    • Severe cyanosis
    • Tachycardia
    • Severe dyspnea indicating pulmonary congestion and LV failure
    • Edema
    • Limited peripheral manifestations
    • No significant widening of pulse pressure
    • May relate to acute mitral valve regurgitation and premature closure of mitral valve
    • Pulmonary hypertension with S3, S4, and loud P2
    • Low-pitched short early diastolic murmur: In extremely severe aortic valve insufficiency, when LV decompensation occurs, a significant part of the murmur is diminished as an equalization of pressure occurs between the aorta and the LV in the latter part of diastole.
    • Shortened (or absent) Austin Flint murmur, with no presystolic component because of premature closure of the mitral valve during diastole

Causes

  • Causes of aortic valve insufficiency include congenital malformations of the aortic valves and diseases of the aortic valves and root.
  • See Pathophysiology for further discussion of causes.

More on Aortic Valve Insufficiency

Overview: Aortic Valve Insufficiency
Differential Diagnoses & Workup: Aortic Valve Insufficiency
Treatment & Medication: Aortic Valve Insufficiency
Follow-up: Aortic Valve Insufficiency
Multimedia: Aortic Valve Insufficiency
References

References

  1. Gentles TL, Colan SD, Wilson NJ, et al. Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol. Jan 2001;37(1):201-7. [Medline].

  2. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. Oct 7 2008;118(15):e523-661. [Medline].

  3. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. Sep 15 1994;331(11):689-94. [Medline].

  4. Pasquali SK, Shera D, Wernovsky G, et al. Midterm outcomes and predictors of reintervention after the Ross procedure in infants, children, and young adults. J Thorac Cardiovasc Surg. Apr 2007;133(4):893-9. [Medline].

  5. Kouchoukos NT, Masetti P, Nickerson NJ, et al. The Ross procedure: long-term clinical and echocardiographic follow-up. Ann Thorac Surg. Sep 2004;78(3):773-81; discussion 773-81. [Medline].

  6. Elkins RC, Lane MM, McCue C. Ross operation in children: late results. J Heart Valve Dis. Nov 2001;10(6):736-41. [Medline].

  7. Lupinetti FM, Duncan BW, Lewin M, Dyamenahalli U, Rosenthal GL. Comparison of autograft and allograft aortic valve replacement in children. J Thorac Cardiovasc Surg. Jul 2003;126(1):240-6. [Medline].

  8. Elkins RC, Knott-Craig CJ, McCue C, Lane MM. Congenital aortic valve disease. Improved survival and quality of life. Ann Surg. May 1997;225(5):503-10; discussion 510-1. [Medline].

  9. Luciani GB, Favaro A, Casali G, Santini F, Mazzucco A. Ross operation in the young: a ten-year experience. Ann Thorac Surg. Dec 2005;80(6):2271-7. [Medline].

  10. Takkenberg JJ, van Herwerden LA, Eijkemans MJ, Bekkers JA, Bogers AJ. Evolution of allograft aortic valve replacement over 13 years: results of 275 procedures. Eur J Cardiothorac Surg. Apr 2002;21(4):683-91; discussion 691. [Medline].

  11. [Guideline] Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. Oct 9 2007;116(15):1736-54. [Medline].

  12. Bolen JL, Alderman EL. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation. May 1976;53(5):879-83. [Medline].

  13. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Val. J Heart Valve Dis. Nov 1998;7(6):672-707. [Medline].

  14. Bonow RO, Dodd JT, Maron BJ, et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation. Nov 1988;78(5 Pt 1):1108-20. [Medline].

  15. Bonow RO, Rosing DR, Maron BJ, et al. Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation. Oct 1984;70(4):570-9. [Medline].

  16. Braunwald. Heart Disease: A Textbook of Cardiovascular Medicine. Vol 1. 1997:1045-60.

  17. Cameron DE. Surgical techniques. Ascending aorta. Cardiol Clin. Nov 1999;17(4):739-50. [Medline].

  18. Carabello BA. Vasodilators in aortic regurgitation--where is the evidence of their effectiveness?. N Engl J Med. Sep 29 2005;353(13):1400-2. [Medline].

  19. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med. Jul 3 1997;337(1):32-41. [Medline].

  20. David TE, Ivanov J, Armstrong S, Feindel CM, Webb GD. Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta. Ann Thorac Surg. Nov 2002;74(5):S1758-61; discussion S1792-9. [Medline].

  21. Ekery DL, Davidoff R. Aortic regurgitation: quantitative methods by echocardiography. Echocardiography. Apr 2000;17(3):293-302. [Medline].

  22. Elkins RC. The Ross operation: applications to children. Semin Thorac Cardiovasc Surg. Oct 1996;8(4):345-9. [Medline].

  23. Fedderly RT. Left ventricular outflow obstruction. Pediatr Clin North Am. Apr 1999;46(2):369-84. [Medline].

  24. Fioretti P, Benussi B, Scardi S, et al. Afterload reduction with nifedipine in aortic insufficiency. Am J Cardiol. May 1982;49(7):1728-32. [Medline].

  25. Grande KJ, Cochran RP, Reinhall PG, Kunzelman KS. Mechanisms of aortic valve incompetence: finite element modeling of aortic root dilatation. Ann Thorac Surg. Jun 2000;69(6):1851-7. [Medline].

  26. Greenberg BH, DeMots H, Murphy E, Rahimtoola S. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency. Circulation. Jul 1980;62(1):49-55. [Medline].

  27. Grocott-Mason RM, Lund O, Elwidaa H, et al. Long-term results after aortic valve replacement in patients with congestive heart failure. Homografts vs prosthetic valves. Eur Heart J. Oct 2000;21(20):1698-707. [Medline].

  28. Harris KM, Malenka DJ, Haney MF, et al. Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol. Sep 15 1997;80(6):741-5. [Medline].

  29. Ismailov RM, Weiss HB, Ness RB, et al. Blunt cardiac injury associated with cardiac valve insufficiency: trauma links to chronic disease?. Injury. Sep 2005;36(9):1022-8. [Medline].

  30. Katz NM. Current surgical treatment of valvular heart disease. Am Fam Physician. Aug 1995;52(2):559-68. [Medline].

  31. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol. Nov 1 1996;28(5):1083-91. [Medline].

  32. Pasquali SK, Cohen MS, Shera D, et al. The relationship between neo-aortic root dilation, insufficiency, and reintervention following the Ross procedure in infants, children, and young adults. J Am Coll Cardiol. May 1 2007;49(17):1806-12. [Medline].

  33. Shah PM, Graham BM. Management of aortic stenosis: is cardiac catheterization necessary?. Am J Cardiol. May 1 1991;67(11):1031-2. [Medline].

  34. Shiota T, Jones M, Aida S, et al. Calculation of aortic regurgitant volume by a new digital Doppler color flow mapping method: an animal study with quantified chronic aortic regurgitation. J Am Coll Cardiol. Sep 1997;30(3):834-42. [Medline].

Further Reading

Keywords

aortic valve insufficiency, aortic insufficiency, AI, aortic regurgitation, AR, aortic valve incompetence, aortic valve prolapse, aortic valve insufficiency, abnormalities in the aortic valve leaflets, diagnosis, treatment

Contributor Information and Disclosures

Author

Mohsen Saidinejad, MD, Assistant Professor of Pediatrics and Emergency Medicine, George Washington University School of Medicine and Health Sciences; Attending Physician, Department of Pediatric Emergency Medicine, Children's National Medical Center
Mohsen Saidinejad, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians, and American Public Health Association
Disclosure: Nothing to disclose.

Coauthor(s)

Russell R Cross, MD, Assistant Professor of Pediatrics, George Washington University Medical Center; Attending Cardiologist, Director of Cardiac MRI, Division of Cardiology, Medical Unit Director of Heart and Kidney Unit, Children's National Medical Center-Main Hospital
Russell R Cross, MD is a member of the following medical societies: American College of Cardiology, American Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance
Disclosure: Nothing to disclose.

Medical Editor

Christopher Johnsrude, MD, Associate Professor of Pediatrics, Director of Electrophysiology, University of Louisville School of Medicine; Consulting Staff, Pediatric Cardiology Associates, PSC
Christopher Johnsrude, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Cardiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Alvin J Chin, MD, Professor of Pediatrics, Division of Cardiology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine
Alvin J Chin, MD is a member of the following medical societies: American Association for the Advancement of Science and American Heart Association
Disclosure: Nothing to disclose.

CME Editor

Gilbert Z Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College; Consulting Staff, Department of Pediatrics, Sound Shore Medical Center
Gilbert Z Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD, Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin
Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.